S&P 5007,713▲ 0.28%Nasdaq26,425▼ 0.02%Dow Jones52,496▲ 1.02%Nasdaq 10029,490▼ 0.13%VIX17.31▼ 6.13%US Dollar101.71▼ 0.27%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › AET › Research report
← AET page
XStocksXray
Market X-Ray report · 19 October 2026

Afentra PLC (AET)

London Exchange · UK · prices in GBX · close of 19 Oct 2026

Key indicators

Last closeGBX 74.60
52-week range36.70 – 89.40
Return, 1 month / 3 months−3.7% / +16.9%
Return, 1 year / 3 years+76.4% / +173.3%
TrendAbove 200-day, below 50-day
RSI (14)52
Volatility (1 year)49.3%
Worst drawdown (1 year)-33.3%
Average daily value traded63.82M GBX
Dividend yield–

Market X-Ray price-based

65/ 100 · High confidence · ahead of 75% of stocks on this exchange
Trend73
Momentum73
Stability (higher is calmer)35
Liquidity86
Income–

Five-year price chart navy: price · brown: 200-day average

10.2130.4750.7270.9891.242022-052023-102024-102025-102026-10

About the company

Afentra PLC is an oil and gas company focused on Africa. It acquires interests in producing and development oil and gas assets, working with partners and host governments in countries such as Angola. The company is based in the United Kingdom and its activities centre on upstream exploration and production, generating revenue from the sale of crude oil from the fields in which it holds stakes.

Afentra PLC trades under the code AET on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Afentra PLC (AET) trades on the London Exchange in UK. It last closed at GBX 74.60 on 19 October 2026.

Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 933 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 76.4% and over the last three months it rose 16.9%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Afentra PLC (AET)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend73 · StrongTrading above its long-term averages and near its highs.
Above 200-day average12.1%
From 52-week high-14.2%
Momentum73 · StrongRising faster than most stocks on this exchange.
3-month return16.9%
6-month return-4.4%
12-month return, skipping the last month83.2%
Stability (higher is calmer)35 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)49.3%
Worst drawdown, 1 year (smaller is calmer)-33.3%
Liquidity86 · StrongTrades actively.
Average daily value traded63.82M GBX
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.
  • Liquidity: Trades actively.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week+2.2%
1 month−3.7%
3 months+16.9%
6 months−4.4%
1 year+76.4%
3 years+173.3%
5 years–

Signals

50-day / 200-day average75.01 / 66.55
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)4.09

Technical summary

DailyBullish10 bullish · 4 neutral · 2 bearish
WeeklyStrongly bullish10 bullish · 1 neutral · 1 bearish
MonthlyStrongly bullish7 bullish · 1 neutral · 0 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026